At last month’s AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference, CRT hosted a successful networking event at the Prudential Center, Boston.
The conference bought together an estimated 3,000 academics, scientists, and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection, and the impact of new discoveries in molecular biology. It therefore provided an ideal opportunity for staff from CRT and Cancer Research UK to meet and socialise with oncology colleagues.
From the 52nd floor venue, guests were able to enjoy good food while taking in the spectacular autumnal views of Boston. The intimate and informal structure of the event helped to stimulate engaging conversation and lively discussion between colleagues and peers.
Larry Steranka, managing director of CRT Inc. said: “With attendees from a wide range of companies and a relaxed agenda designed to maximise networking time, the event provided an opportunity to interact and socialise with new and existing partners, discuss recent initiatives and developments, and enjoy good food and conversation. We’d like to thank all of those who attended and look forward to hosting similar events in the future.”